Enovix Corporation (ENVX) Financial Statements
Enovix Corporation (ENVX) reported trailing twelve-month revenue of $35.9M (up 34.9% year on year) and net income of -$170.0M as of 2026-07-05, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$124.2M.
Source: SEC EDGAR filings · figures as of 2026-07-05 · read by EquiReason
- Market cap
- 612.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26. Results for the next quarter were released 13 Oct; these figures move once the 10-Q is filed.
| Line | FY2022 Jan 23 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 6.2 | 7.6 | 23.1 | 31.8 | 35.9 | |
| Gross profit | -17.0 | -55.4 | -2.0 | 6.1 | 6.8 | |
| Research & development | 58.1 | 88.4 | 124.5 | 110.3 | 107.2 | |
| Operating income | -132.0 | -230.3 | -242.7 | -177.3 | -178.2 | |
| Pre-tax income | -51.6 | -214.8 | -223.9 | -157.9 | -171.0 | |
| Income tax | 0.0 | -0.6 | -1.4 | -1.3 | -0.9 | |
| Net income | -51.6 | -214.1 | -222.2 | -156.7 | -170.0 | |
| Diluted EPS ($) | -0.82 | -1.30 | -1.19 | -0.75 | -0.81 | |
| Diluted shares (mn) | 154.1 | 169.6 | 186.0 | 207.6 | — |
USD millions · SEC XBRL
Enovix Corporation — questions
- What is Enovix Corporation's revenue?
- $35.9M over the twelve months to 2026-07-05, up 34.9% year on year, from its 10-Q and 10-K filings.
- What is Enovix Corporation's net income?
- -$170.0M over the twelve months to 2026-07-05.
- What is Enovix Corporation's free cash flow?
- -$124.2M over the twelve months to 2026-07-05.
- What are Enovix Corporation's diluted earnings per share?
- $-0.81 over the twelve months to 2026-07-05.
Every figure on this page comes from Enovix Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.